2018 has allowed a better understanding of environment-host-microbiome interactions in shaping health and disease. We’re pleased to present the new “Year at a Glance 2018” document, which summarizes the relevant advances in gut microbiota science 2018.
Regular use of probiotics in infants and children can significantly reduce the need for antibiotic treatment during childhood, which, in turn, would slow down the development of antibiotic resistance.
The most significant achievements in gut microbiome science in 2018
27 Dec 2018by GMFH Editing Team
GMFH continue to cover the important progress made in our knowledge of the gut microbiota's impact on wellbeing and disease.
Hospital delivery may have short-term implications for both maternal vaginal and neonate fecal microbiota
10 Dec 2018by GMFH Editing Team
The researchers analyzed the structure of stool microbiota from vaginally.
Gut microbe populations in healthy adults may achieve almost full recovery after short-term antibiotics intervention
6 Dec 2018by Andreu Prados
A new study, led by Prof. Oluf Pedersen from the Faculty of Health and Medical Sciences at the University of Copenhagen (Denmark), has found that most gut bacterial species recover.
New GMFH “best of” document highlights the latest research on the gut barrier
19 Nov 2018by GMFH Editing Team
Western diets high in fats and sugars, modern lifestyles with stress and sedentarism and the indiscriminate use of antibiotics together with other frequently prescribed drugs -such as non-steroidal anti-inflammatory drugs and proton pump inhibitors- are major drivers of changes in microbiota composition and gut barrier disruption. (Dr. Maria Rescigno)
The source of antibiotic resistance genes in the infant gut may rely on the mother’s gut and breast milk microbiota
18 Oct 2018by Andreu Prados
A new study has found that maternal gut and breast milk microbiomes may contribute to infant acquisition of antibiotic resistance genes and mobile genetic elements.
A recent Cochrane review shows that probiotics appear to be effective and safe in preventing Clostridium difficile infection
27 Aug 2018by Paul Enck
A new systematic review and meta-analysis concludes that probiotics are associated with a lower risk of symptomatic C. difficile infection.
Rifamixin may modulate the neural signature of social stress via our gut microbiota in healthy volunteers
24 May 2018by Paul Enck
A new double-blinded randomized study has found that rifaximin—a poorly absorbable antibiotic acting mainly in the gut —may exhibit stress-reducing effects by modulating our gut microbiota in a way similar to probiotics.
A new study profiles interactions between a range of non-antibiotic drugs and the human gut microbiota
16 Apr 2018by Andreu Prados
A recent study has found that many non-antibiotic human-targeted drugs may have a direct effect on the gut microbiome that potentially contribute to both their gastrointestinal side effects and therapeutic actions.